13F Holdings
中文EN

Trails Edge Capital Partners, LP

ATLANTA GA · SEC CIK 0002077247

2026Q22026Q1 9 earlier quarters 🔒
$629.91M2026Q2 reported value
35Positions
50.3%Top 10 weight · largest 7.8%
10 / 5New / sold out
Reported value over time$629.91M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

LBRX 7.8%
NRIX 6.1%
IMCR 5.4%
TRAX 4.8%
FDMT 4.7%
BMRN 4.7%
DSGN 4.6%
XENE 4.2%
MIRM 4.2%
INSM 3.9%

2026Q2 top buys estimated at quarter-end value

BMRN New+$29.30M
INSM New+$24.56M
INCY New+$17.57M
DSGN Added+$16.63M
AVTX New+$16.48M

2026Q2 top sells estimated at quarter-end value

PCVX Sold out-$38.50M
DFTX Sold out-$32.85M
RVMD Reduced-$24.21M
RCUS Sold out-$22.64M
MIRM Reduced-$12.88M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
LBRX LB PHARMACEUTICALS INC $49.43M7.85%1,523,022 203,66015.4% $6.61M Added
NRIX NURIX THERAPEUTICS INC $38.17M6.06%1,573,220 -170,000-9.8% -$4.12M Reduced
IMCR IMMUNOCORE HLDGS PLC $33.76M5.36%1,063,234 380,63755.8% $12.09M Added
TRAX FIRST TRACKS BIOTHERAPEUTICS $30.46M4.84%1,514,000 1,514,000— — First reported
FDMT 4D MOLECULAR THERAPEUTICS IN $29.63M4.70%2,227,917 925,00071.0% $12.30M Added
BMRN BIOMARIN PHARMACEUTICAL INC $29.30M4.65%512,000 512,000— $29.30M New
DSGN DESIGN THERAPEUTICS INC $28.96M4.60%2,001,282 1,149,269134.9% $16.63M Added
XENE XENON PHARMACEUTICALS INC $26.56M4.22%440,000 00.0% — Unchanged
MIRM MIRUM PHARMACEUTICALS INC $26.14M4.15%223,312 -110,000-33.0% -$12.88M Reduced
INSM INSMED INC $24.56M3.90%230,331 230,331— $24.56M New
CYTK CYTOKINETICS INC $24.54M3.90%288,089 -11,911-4.0% -$1.01M Reduced
SNDX SYNDAX PHARMACEUTICALS INC $24.26M3.85%1,110,000 408,17958.2% $8.92M Added
NGNE NEUROGENE INC $22.48M3.57%714,885 -67,902-8.7% -$2.14M Reduced
KLRA KAILERA THERAPEUTICS INC $21.69M3.44%984,786 984,786— — First reported
RVMD REVOLUTION MEDICINES INC $21.68M3.44%115,750 -129,250-52.8% -$24.21M Reduced
IKT INHIBIKASE THERAPEUTICS INC $18.37M2.92%9,051,318 993,97312.3% $2.02M Added
INCY INCYTE CORP $17.57M2.79%155,000 155,000— $17.57M New
AVTX AVALO THERAPEUTICS INC $16.48M2.62%891,881 891,881— $16.48M New
MLTX MOONLAKE IMMUNOTHERAPEUTICS $14.60M2.32%750,000 750,000— $14.60M New
FTH FAETH THERAPEUTICS INC $12.88M2.05%515,335 390,335312.3% $9.76M Added
XFOR X4 PHARMACEUTICALS INC $12.01M1.91%2,571,478 00.0% — Unchanged
IRD OPUS GENETICS INC $11.28M1.79%2,743,658 2,243,658448.7% $9.22M Added
— SOL-GEL TECHNOLOGIES LTD $10.34M1.64%139,445 53,94963.1% $4.00M Added
AURA AURA BIOSCIENCES INC $10.25M1.63%1,443,333 1,443,333— $10.25M New
IPSC CENTURY THERAPEUTICS INC $10.13M1.61%4,134,969 1,684,97668.8% $4.13M Added
IVA INVENTIVA SA $10.05M1.60%2,657,997 00.0% — Unchanged
CAMP CAMP4 THERAPEUTICS CORP $8.45M1.34%1,932,937 -6,626-0.3% -$28,956 Reduced
ALT ALTIMMUNE INC $8.09M1.28%2,660,000 2,660,000— $8.09M New
NERV MINERVA NEUROSCIENCES INC $7.88M1.25%1,419,000 00.0% — Unchanged
— PROMIS NEUROSCIENCES INC $7.33M1.16%557,103 00.0% — Unchanged
OKUR ONKURE THERAPEUTICS INC $6.56M1.04%1,438,456 1,438,456— $6.56M New
— FORTE BIOSCIENCES INC $5.81M0.92%273,181 273,181— $5.81M New
— RESEARCH ALLIANCE CORP III $5.35M0.85%500,000 500,000— — First reported
— VTV THERAPEUTICS INC $3.21M0.51%85,192 -54,386-39.0% -$2.05M Reduced
— IMAGENEBIO INC $1.66M0.26%282,004 282,004— $1.66M New
PCVX VAXCYTE INC $00.00%0 -662,470-100.0% -$38.50M Sold out
DFTX DEFINIUM THERAPEUTICS INC $00.00%0 -1,738,110-100.0% -$32.85M Sold out
RCUS ARCUS BIOSCIENCES INC $00.00%0 -1,047,935-100.0% -$22.64M Sold out
XENE XENON PHARMACEUTICALS INC Put $00.00%0 -200,000-100.0% -$11.63M Sold out
IMVT IMMUNOVANT INC $00.00%0 -414,054-100.0% -$10.29M Sold out